2.86 USD
↘ 0.07 (2.23%)LIVE (AS OF 03:20 PM EDT)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
Market: OPEN
Shares of Acumen Pharmaceuticals, Inc. Common Stock (ABOS) are trading at $2.86. ABOS shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, ABOS trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Sep 11, 2026.
Open?$2.91
High?$3.02
Low?$2.86
Prev. Close?$2.92
Volume?296.9K
Avg. Volume?347.6K
VWAP?$2.94
Rel. Volume?0.85x
Bid / Ask
Bid?$2.88 × 100
Ask?$2.89 × 500
Spread?$0.01
Midpoint?$2.89
Valuation & Ratios
Market Cap?211.2M
Shares Out?72.3M
Float?37.4M
Float %?51.8%
P/E Ratio?N/A
P/B Ratio?3.69
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
211.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.16Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?8.45%Elevated
Short Interest?3.2M
Days to Cover?8.2
Free Float37.4M
Avg Daily Volume384.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.47Strong
Quick Ratio?2.47Strong
Cash Ratio?1.27Strong
Debt/Equity?0.55Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.69FAIR▾
Peers100
S&P47
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-183.4%WEAK▾
S&P3
ROA?-90.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-91788000
Enterprise Value?$183.3M
Fundamentals ratios updated end of day